Innovative Drug Delivery Nano Precision Medical specializes in developing sub-dermal drug implants using proprietary NanoPortal technology, enabling long-term medication delivery for chronic disease management. This unique approach presents sales opportunities with healthcare providers and pharmaceutical partners seeking advanced adherence solutions.

Recent Strategic Mergers The company's merger with Second Sight Medical Products and subsequent formation of Vivani Medical indicates a strategic expansion into the medical device and neuro-implant market, opening doors for collaborative opportunities and new market segments.

Growth and Funding With a funding level of $13 million and revenues ranging from one to ten million dollars, Nano Precision Medical demonstrates solid financial positioning that supports sales efforts targeting biopharmaceuticals and device manufacturers investing in innovative healthcare technologies.

Industry Partnerships Strategic collaborations, such as the partnership with Okavapharma focused on aging-related diseases, highlight potential opportunities to offer tailored solutions or joint ventures in niche markets including veterinary medicine and age-related treatments.

Technological Capabilities Utilizing advanced software like SOLIDWORKS and development platforms including Ruby on Rails, Nano Precision Medical is positioned as a tech-savvy innovator, appealing to clients and partners interested in cutting-edge biomedical technologies and scalable manufacturing processes.